Imagine being able to answer your product’s most challenging safety & effectiveness questions before you even recruit clinical trial participants.

  The key is in our genes.

  Genetic technologies are evolving, with significant impact on the pharma & biotech industry.

  Don Gabriel, MD, PhD, serves as UBC’s consultant Senior Director of Medical Oncology & Scientific Strategy. He is a nationally recognized oncology hematologist with more than 30 years of experience.

  Scroll down & let Dr. Don take you on an educational tour of how these technologies are impacting every phase of the product lifecycle.

REFERENCE:  1. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med 2011; 364: 1144–1153. | Article | PubMed | ISI | CAS |

© 2018 United Biosource LLC. All Rights Reserved.